All Stories

  1. Clinical and angiographic outcomes following percutaneous treatment of chronic totally occluded versus non-totally occluded coronary vessels

    Article • Canadian Journal of Cardiology, April 2026, Elsevier

    MD, PhD Erion Xhepa

  2. Relationship Between Perivascular Fat Inflammation and Coronary Atherosclerotic Plaque Composition

    Article • Journal of Clinical Medicine, February 2026, MDPI AG

    MD, PhD Erion Xhepa

  3. Clinical and angiographic outcomes following percutaneous treatment of chronic totally occluded versus non-totally occluded coronary vessels

    Article • Canadian Journal of Cardiology, February 2026, Elsevier

    MD, PhD Erion Xhepa

  4. RV-PA Uncoupling Is Associated With 1-Year Mortality in ST-Segment Elevation Myocardial Infarction

    Article • JACC Cardiovascular Interventions, January 2026, Elsevier

    MD, PhD Erion Xhepa

  5. Strategy for pacemaker implantation following transcatheter tricuspid valve replacement: A real world single centre experience

    Article • Journal of Interventional Cardiac Electrophysiology, December 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  6. Long-term safety and efficacy of rotational atherectomy for lesion preparation of calcified coronary lesions

    Article • International Journal of Cardiology, December 2025, Elsevier

    MD, PhD Erion Xhepa

  7. Predictors of underexpansion after transcatheter aortic valve implantation with the ACURATE neo valve

    Article • EuroIntervention, December 2025, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  8. Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis

    Article • Clinical Research in Cardiology, November 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  9. Percutaneous femoral access closure and prognosis following transcatheter aortic valve replacement: A systematic review and meta-analysis

    Article • The Journal of Vascular Access, November 2025, SAGE Publications

    MD, PhD Erion Xhepa

  10. Influence of device evolution in MitraClip and PASCAL systems on clinical outcomes in high-risk patients with degenerative mitral regurgitation and complex anatomy: results from the PRIME-MR registry

    Article • European Heart Journal, November 2025, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  11. Predictive factors for persisting excess symptoms following transcatheter edge-to-edge repair for degenerative mitral regurgitation: Results of the worldwide, multicenter PRIME-MR registry

    Article • European Heart Journal, November 2025, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  12. Acute Occlusion of Right Coronary Artery During Transcatheter Aortic Valve Replacement of a Bicuspid Valve

    Article • JACC Case Reports, October 2025, Elsevier

    MD, PhD Erion Xhepa

  13. Drug-Coated Balloon Therapy for Chronic Total Coronary Occlusions

    Article • JACC Cardiovascular Interventions, September 2025, Elsevier

    MD, PhD Erion Xhepa

  14. Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis

    Article • Circulation, August 2025, Wolters Kluwer Health

    Dr. Yuji Matsuda, MD, PhD Erion Xhepa

  15. Treatment Strategies for Patients with Mitral Regurgitation: A Meta-Analysis of Randomized Controlled Trials

    Article • Journal of Personalized Medicine, August 2025, MDPI AG

    MD, PhD Erion Xhepa

  16. Intravascular Imaging for Stent Failure - Current Status and Future Perspectives

    Article • Current Cardiovascular Imaging Reports, July 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  17. Transcatheter Mitral Valve Implantation Compared to Surgery: One-Year Clinical Outcome

    Article • The Thoracic and Cardiovascular Surgeon, July 2025, Thieme Publishing Group

    MD, PhD Erion Xhepa

  18. Intracoronary Stenting and Restenosis – Randomized Trial of Drug-Eluting Stent Implantation or Drug-Coated Balloon Angioplasty According to Neointima Morphology in Drug-Eluting Stent REstenosis 5: Rationale and Design of the ISAR-DESIRE 5 Trial

    Article • Journal of Cardiovascular Translational Research, June 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  19. Bioprosthetic Valve Fracturing in Valve‐in‐Valve TAVI: Clinical and Echocardiographic Outcomes in Failing Perimount Aortic Bioprostheses—A Multicenter Registry

    Article • Catheterization and Cardiovascular Interventions, June 2025, Wiley

    MD, PhD Erion Xhepa

  20. Prognostic value of NT‐proBNP in patients with primary mitral regurgitation undergoing transcatheter edge‐to‐edge repair

    Article • European Journal of Heart Failure, June 2025, Wiley

    MD, PhD Erion Xhepa

  21. Employment of artificial intelligence for an unbiased evaluation regarding the recovery of right ventricular function after mitral valve transcatheter edge‐to‐edge repair

    Article • European Journal of Heart Failure, June 2025, Wiley

    MD, PhD Erion Xhepa

  22. Long term follow up of patients treated with a polymer coated non drug-eluting stent in the COBRA-REDUCE trial

    Article • Cardiovascular Revascularization Medicine, June 2025, Elsevier

    MD, PhD Erion Xhepa

  23. Aortic valve calcification volume and prognosis in patients undergoing transcatheter aortic valve implantation

    Article • Revista Española de Cardiología (English Edition), June 2025, Elsevier

    MD, PhD Erion Xhepa

  24. Correction: Sex-specific outcomes in myocardial infarction: a dual-cohort analysis using clinical and real-world data

    Article • Clinical Research in Cardiology, May 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  25. Mid- to long-term outcomes of covered balloon-expandable stent implantation for the management of vascular injuries in patients undergoing transfemoral transcatheter aortic valve implantation: the BE-SAFE Registry

    Article • Clinical Research in Cardiology, May 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  26. Deep learning model DeepNeo predicts neointimal tissue characterization using optical coherence tomography

    Article • Communications Medicine, April 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  27. Intracoronary stenting and additional results achieved by shockWAVE coronary lithotripsy: design and rationale of ISAR-WAVE trial

    Article • American Heart Journal, April 2025, Elsevier

    MD, PhD Erion Xhepa

  28. Sex-specific outcomes in myocardial infarction: a dual-cohort analysis using clinical and real-world data

    Article • Clinical Research in Cardiology, March 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  29. The Impact of Underlying Plaque Characteristics Following the Third‐Generation Resorbable Magnesium Scaffold Implantation: An Intravascular OCT Assessment up to 12‐Months

    Article • Catheterization and Cardiovascular Interventions, March 2025, Wiley

    MD, PhD Erion Xhepa

  30. Body Mass Index and 10-Year Clinical Outcomes After Percutaneous Coronary Intervention—Interaction with Age, Sex, Diabetic Status and Clinical Presentation

    Article • Journal of Clinical Medicine, February 2025, MDPI AG

    MD, PhD Erion Xhepa

  31. Comparative safety and efficacy of new-generation single-layer polytetrafluorethylene- versus polyurethane-covered stents in patients with coronary artery perforation for the RECOVER (REsults after percutaneous interventions with COVERed stents) Invest...

    Article • Cardiovascular Intervention and Therapeutics, February 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  32. Impact of GDMT on outcomes after mitral valve edge-to-edge repair stratified by SMR proportionality

    Article • Clinical Research in Cardiology, February 2025, Springer Science + Business Media

    MD, PhD Erion Xhepa

  33. Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease

    Article • JAMA Cardiology, February 2025, American Medical Association (AMA)

    MD, PhD Erion Xhepa

  34. Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis

    Article • Revista Española de Cardiología (English Edition), February 2025, Elsevier

    MD, PhD Erion Xhepa

  35. Body Mass Index and 10-year Clinical Outcomes After Percutaneous Coronary Intervention - Interaction With Age, Sex, Diabetic Status and Clinical Presentation

    Article • January 2025, MDPI AG

    MD, PhD Erion Xhepa

  36. Deep Learning–Enabled Assessment of Right Ventricular Function Improves Prognostication After Transcatheter Edge-to-Edge Repair for Mitral Regurgitation

    Article • Circulation Cardiovascular Imaging, January 2025, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  37. Left ventricular systolic function after percutaneous coronary intervention: patterns of change and prognosis according to clinical presentation of coronary artery disease

    Article • Clinical Research in Cardiology, December 2024, Springer Science + Business Media

    MD, PhD Erion Xhepa

  38. Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine Care

    Article • JAMA Network Open, December 2024, American Medical Association (AMA)

    MD, PhD Erion Xhepa

  39. Impaired Kidney Function and 10-Year Outcome After Percutaneous Coronary Intervention—Interaction with Age, Sex, Diabetic Status and Clinical Presentation

    Article • Journal of Clinical Medicine, November 2024, MDPI AG

    MD, PhD Erion Xhepa

  40. Abstract 4138386: Deep Learning-Enabled Assessment of Right Ventricular Function Using 2D Echocardiograms Improves 1-Year Mortality Prediction in Patients with Severe Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair

    Article • Circulation, November 2024, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  41. Abstract 4147282: Systemic inflammation after STEMI – impact on infarct size and outcome –

    Article • Circulation, November 2024, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  42. Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation

    Article • JACC Cardiovascular Interventions, November 2024, Elsevier

    MD, PhD Erion Xhepa

  43. Comparison of strategies for vascular ACCESS closure after Transcatheter Aortic Valve Implantation: the ACCESS-TAVI randomized trial

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  44. Left Ventricular Ejection Fraction Change Following Percutaneous Coronary Intervention: Correlates and Association With Prognosis

    Article • Journal of the American Heart Association, October 2024, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  45. A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary Stenting

    Article • Journal of Clinical Medicine, October 2024, MDPI AG

    MD, PhD Erion Xhepa

  46. Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction

    Article • Hämostaseologie, October 2024, Thieme Publishing Group

    MD, PhD Erion Xhepa

  47. New-generation single-layer PTFE-covered coronary stent for endovascular repair of iatrogenic arterial side-branch injury in non-coronary lesions for the RECOVER (REsults after percutaneous interventions with COVERed stents) Investigators

    Article • Cardiovascular Revascularization Medicine, October 2024, Elsevier

    MD, PhD Erion Xhepa

  48. Randomized Trial of COBRA PzF Stenting to Reduce the Duration of Triple Therapy: The COBRA-REDUCE Trial

    Article • Circulation Cardiovascular Interventions, October 2024, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  49. Elevated mitral valve pressure gradient following transcatheter edge-to-edge repair is independently associated with inferior outcomes in atrial, but not in ventricular secondary mitral regurgitation

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  50. The prognostic impact of intra-procedural mitral valve gradient following transcatheter edge-to-edge repair for primary mitral regurgitation

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  51. Comparative long‐term efficacy and safety of two paclitaxel‐coated balloons with different coating strategies for the treatment of drug‐eluting coronary stent restenosis

    Article • Catheterization and Cardiovascular Interventions, September 2024, Wiley

    MD, PhD Erion Xhepa

  52. Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study

    Article • EuroIntervention, September 2024, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  53. Outcomes after transcatheter mitral valve implantation in valve‐in‐valve, valve‐in‐ring, and valve‐in‐mitral annular calcification

    Article • Catheterization and Cardiovascular Interventions, July 2024, Wiley

    MD, PhD Erion Xhepa

  54. Impact of Intraprocedural Mitral Regurgitation and Gradient Following Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation

    Article • JACC Cardiovascular Interventions, July 2024, Elsevier

    MD, PhD Erion Xhepa

  55. DeepNeo: Deep Learning for neointimal tissue characterization using optical coherence tomography

    Article • June 2024, Cold Spring Harbor Laboratory Press

    MD, PhD Erion Xhepa

  56. Noncalcific Transcatheter Heart Valve Dysfunction

    Article • JACC Cardiovascular Interventions, June 2024, Elsevier

    MD, PhD Erion Xhepa

  57. Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel

    Article • Clinical Research in Cardiology, May 2024, Springer Science + Business Media

    MD, PhD Erion Xhepa

  58. Transcatheter or Surgical Treatment of Aortic-Valve Stenosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2024, New England Journal of Medicine (NEJM/MMS)

    MD, PhD Erion Xhepa

  59. Invasive Assessment of Right Ventricular to Pulmonary Artery Coupling Improves 1-year Mortality Prediction After Transcatheter Aortic Valve Replacement and Anticipates the Persistence of Extra-Aortic Valve Cardiac Damage

    Article • Structural Heart, May 2024, Elsevier

    MD, PhD Erion Xhepa

  60. Systemic inflammatory response syndrome in patients undergoing transcatheter aortic valve implantation

    Article • Cardiovascular Revascularization Medicine, May 2024, Elsevier

    MD, PhD Erion Xhepa

  61. A Ten-Year Follow-Up Study of the Association Between Uric Acid and Adverse Cardiovascular Events in Patients With Coronary Artery Disease

    Article • The American Journal of Cardiology, April 2024, Elsevier

    MD, PhD Erion Xhepa

  62. Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry

    Article • EuroIntervention, March 2024, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  63. Plug-based bailout after failed suture-based large-bore vascular access closure: one more arrow in the quiver for experienced hands?

    Article • EuroIntervention, March 2024, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  64. Aspirin loading and coronary no‐reflow after percutaneous coronary intervention in patients with acute myocardial infarction

    Article • European Journal of Clinical Investigation, January 2024, Wiley

    MD, PhD Erion Xhepa

  65. Update zur Behandlung der Aortenklappenstenose bei symptomatischen und asymptomatischen Patienten

    Article • Herz, January 2024, Springer Science + Business Media

    MD, PhD Erion Xhepa

  66. Recurrent Revascularization at 10 Years After Percutaneous Treatment of Drug-Eluting Stent Restenosis

    Article • JACC Cardiovascular Interventions, January 2024, Elsevier

    MD, PhD Erion Xhepa

  67. Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors

    Article • Clinical Research in Cardiology, November 2023, Springer Science + Business Media

    MD, PhD Erion Xhepa

  68. Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials

    Article • Clinical Research in Cardiology, November 2023, Springer Science + Business Media

    MD, PhD Erion Xhepa

  69. Very long-term outlook of acute coronary syndromes after percutaneous coronary intervention with implantation of polymer-free versus durable-polymer new-generation drug-eluting stents

    Article • Minerva Medica, November 2023, Edizioni Minerva Medica

    MD, PhD Erion Xhepa

  70. Implantation depth of balloon‐expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events

    Article • Catheterization and Cardiovascular Interventions, October 2023, Wiley

    MD, PhD Erion Xhepa

  71. Incidence of systemic inflammatory response syndrome and patient outcome following transcatheter edge-to-edge mitral valve repair

    Article • Clinical Research in Cardiology, October 2023, Springer Science + Business Media

    MD, PhD Erion Xhepa

  72. Outcomes of endovascular treatment for popliteal artery disease

    Article • VASA, October 2023, Hogrefe Publishing Group

    MD, PhD Erion Xhepa

  73. Near-infrared spectroscopy-intravascular ultrasound to improve assessment of coronary artery disease severity in patients referred for transcatheter aortic valve implantation (The IMPACTavi registry): Design and rationale

    Article • American Heart Journal, October 2023, Elsevier

    MD, PhD Erion Xhepa

  74. Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation

    Article • EuroIntervention, September 2023, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  75. Fluoroscopic and tomographic correlation for aortic annulus measurements in transcatheter aortic valve implantation: �follow the right cusp� rule

    Article • REC interventional cardiology (English Edition), July 2023, Publicidad Permanyer, SLU

    MD, PhD Erion Xhepa

  76. Clinical Safety and Efficacy of New-Generation Single-Layer Polytetrafluorethylene Covered Coronary Stents

    Article • Cardiovascular Revascularization Medicine, July 2023, Elsevier

    MD, PhD Erion Xhepa

  77. Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range

    Article • Journal of Clinical Medicine, April 2023, MDPI AG

    MD, PhD Erion Xhepa

  78. Multicenter comparison of transcatheter aortic valve implantation with the self-expanding ACURATE neo2 versus Evolut PRO transcatheter heart valves

    Article • Clinical Research in Cardiology, April 2023, Springer Science + Business Media

    MD, PhD Erion Xhepa

  79. Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis

    Article • EuroIntervention, April 2023, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  80. Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease

    Article • EuroIntervention, April 2023, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  81. Randomized ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2: Design and Rationale of the ISAR-CALC 2 Trial

    Article • Cardiovascular Revascularization Medicine, April 2023, Elsevier

    MD, PhD Erion Xhepa

  82. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial

    Article • European Heart Journal, February 2023, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  83. Machine learning identifies pathophysiologically and prognostically informative phenotypes among patients with mitral regurgitation undergoing transcatheter edge-to-edge repair

    Article • European Heart Journal - Cardiovascular Imaging, February 2023, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  84. Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials

    Article • EuroIntervention, February 2023, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  85. Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease

    Article • Catheterization and Cardiovascular Interventions, January 2023, Wiley

    MD, PhD Erion Xhepa

  86. ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation

    Article • EuroIntervention, January 2023, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  87. Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial

    Article • Journal of the American Heart Association, December 2022, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  88. Coronary artery perforation located in a coronary artery bypass graft treated with new-generation single-layer polytetrafluorethylene-covered stent: results from a multicenter Registry

    Article • Coronary Artery Disease, December 2022, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  89. The impact of extra-valvular cardiac damage on mid-term clinical outcome following transcatheter aortic valve replacement in patients with severe aortic stenosis

    Article • Frontiers in Cardiovascular Medicine, December 2022, Frontiers

    MD, PhD Erion Xhepa

  90. Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

    Article • Thrombosis and Haemostasis, November 2022, Thieme Publishing Group

    MD, PhD Erion Xhepa

  91. The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, November 2022, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  92. Frequency of subclavian artery stenosis in patients with mammarian artery coronary bypass and suspected coronary artery disease progression

    Article • Clinical Research in Cardiology, October 2022, Springer Science + Business Media

    MD, PhD Erion Xhepa

  93. Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

    Article • Open Heart, October 2022, BMJ

    MD, PhD Erion Xhepa

  94. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk

    Article • Circulation Cardiovascular Interventions, October 2022, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  95. Right ventricular dysfunction predicts outcome after transcatheter mitral valve repair for primary mitral valve regurgitation

    Article • European Journal of Heart Failure, September 2022, Wiley

    MD, PhD Erion Xhepa

  96. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation

    Article • Journal of Cardiology, September 2022, Elsevier

    MD, PhD Erion Xhepa

  97. Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions

    Article • JACC Cardiovascular Interventions, September 2022, Elsevier

    MD, PhD Erion Xhepa

  98. Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes

    Article • Revista Española de Cardiología (English Edition), September 2022, Elsevier

    MD, PhD Erion Xhepa

  99. Alkaline phosphatase and prognosis in patients with diabetes mellitus and ischemic heart disease

    Article • Clinica Chimica Acta, August 2022, Elsevier

    MD, PhD Erion Xhepa

  100. Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy

    Article • Cardiovascular Revascularization Medicine, August 2022, Elsevier

    MD, PhD Erion Xhepa

  101. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

    Article • Clinical Research in Cardiology, July 2022, Springer Science + Business Media

    MD, PhD Erion Xhepa

  102. Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut

    Article • International Journal of Cardiology, June 2022, Elsevier

    MD, PhD Erion Xhepa

  103. Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary Intervention

    Article • Journal of the American Heart Association, May 2022, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  104. Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis

    Article • Clinical Research in Cardiology, April 2022, Springer Science + Business Media

    MD, PhD Erion Xhepa

  105. Harnessing feature extraction capacities from a pre-trained convolutional neural network (VGG-16) for the unsupervised distinction of aortic outflow velocity profiles in patients with severe aortic stenosis

    Article • European Heart Journal - Digital Health, April 2022, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  106. Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes—a subgroup analysis of the ISAR-REACT 5 trial

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, February 2022, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  107. Target and non-target vessel related events at 10 years post percutaneous coronary intervention

    Article • Clinical Research in Cardiology, February 2022, Springer Science + Business Media

    MD, PhD Erion Xhepa

  108. Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes

    Article • Coronary Artery Disease, January 2022, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  109. Prognostic implications of impaired longitudinal left ventricular systolic function assessed by tissue Doppler imaging prior to transcatheter aortic valve implantation for severe aortic stenosis

    Article • The International Journal of Cardiovascular Imaging, January 2022, Springer Science + Business Media

    MD, PhD Erion Xhepa

  110. Ten-Year Clinical Outcomes in Patients With Acute Coronary Syndrome Treated With Biodegradable, Permanent-Polymer or Polymer-Free Drug-Eluting Stents

    Article • Journal of Invasive Cardiology, January 2022, HMP Communications, LLC

    MD, PhD Erion Xhepa

  111. Histopathology-Based Deep-Learning Predicts Atherosclerotic Lesions in Intravascular Imaging

    Article • Frontiers in Cardiovascular Medicine, December 2021, Frontiers

    MD, PhD Erion Xhepa

  112. Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes

    Article • Clinica Chimica Acta, December 2021, Elsevier

    MD, PhD Erion Xhepa

  113. A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results:...

    Article • Catheterization and Cardiovascular Interventions, November 2021, Wiley

    MD, PhD Erion Xhepa

  114. Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

    Article • Journal of the American Heart Association, November 2021, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  115. 1-Year Results After Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

    Article • JACC Cardiovascular Interventions, October 2021, Elsevier

    MD, PhD Erion Xhepa

  116. Subphenotyping of Patients With Aortic Stenosis by Unsupervised Agglomerative Clustering of Echocardiographic and Hemodynamic Data

    Article • JACC Cardiovascular Interventions, October 2021, Elsevier

    MD, PhD Erion Xhepa

  117. Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention

    Article • JAMA Cardiology, October 2021, American Medical Association (AMA)

    MD, PhD Erion Xhepa

  118. Clinical and angiographic outcomes of crossing techniques for coronary chronic total occlusions: the ISAR-CTO registry

    Article • EuroIntervention, October 2021, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  119. 52 Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap

    Article • October 2021, BMJ

    MD, PhD Erion Xhepa

  120. 8 Stent optimization using optical coherence tomography and its prognostic implications after percutaneous coronary intervention

    Article • October 2021, BMJ

    MD, PhD Erion Xhepa

  121. 9 Target vessel and non-target vessel related events at 10 years post percutaneous coronary intervention

    Article • October 2021, BMJ

    MD, PhD Erion Xhepa

  122. Prognostic value of haemoglobin drop in patients with acute coronary syndromes

    Article • European Journal of Clinical Investigation, September 2021, Wiley

    MD, PhD Erion Xhepa

  123. Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves

    Article • Clinical Research in Cardiology, September 2021, Springer Science + Business Media

    MD, PhD Erion Xhepa

  124. Long‐term clinical outcomes after drug eluting stent implantation with and without stent overlap

    Article • Catheterization and Cardiovascular Interventions, September 2021, Wiley

    MD, PhD Erion Xhepa

  125. Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial

    Article • European Heart Journal Acute Cardiovascular Care, September 2021, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  126. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate

    Article • JACC Cardiovascular Interventions, September 2021, Elsevier

    MD, PhD Erion Xhepa

  127. Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes

    Article • International Journal of Cardiology, September 2021, Elsevier

    MD, PhD Erion Xhepa

  128. Pushing the limits for interventional treatment of aortic valve stenosis

    Article • Herz, August 2021, Springer Science + Business Media

    MD, PhD Erion Xhepa

  129. Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial

    Article • EuroIntervention, August 2021, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  130. Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis

    Article • EuroIntervention, August 2021, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  131. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention

    Article • Circulation Cardiovascular Interventions, July 2021, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  132. Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus

    Article • Clinical Research in Cardiology, June 2021, Springer Science + Business Media

    MD, PhD Erion Xhepa

  133. Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus

    Article • Journal of the American Heart Association, June 2021, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  134. Association between duration of drug-coated balloon inflation and efficacy in patients with drug-eluting stent restenosis

    Article • Coronary Artery Disease, April 2021, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  135. First-in-Man Simultaneous Aortic and Mitral Valve Transcatheter Implantation Using Patient-Customized Prostheses

    Article • JACC Case Reports, April 2021, Elsevier

    MD, PhD Erion Xhepa

  136. Reply

    Article • JACC Cardiovascular Interventions, February 2021, Elsevier

    MD, PhD Erion Xhepa

  137. Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis

    Article • Journal of the American Heart Association, January 2021, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  138. Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation

    Article • The American Journal of Cardiology, January 2021, Elsevier

    MD, PhD Erion Xhepa

  139. Meta-Analysis of Bioprosthetic Valve Thrombosis After Transcatheter Aortic Valve Implantation

    Article • The American Journal of Cardiology, January 2021, Elsevier

    MD, PhD Erion Xhepa

  140. Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials

    Article • Clinical Research in Cardiology, December 2020, Springer Science + Business Media

    MD, PhD Erion Xhepa

  141. Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

    Article • Circulation, December 2020, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  142. Comparison of latest generation supra-annular and intra-annular self-expanding transcatheter heart valves

    Article • Journal of Thoracic Disease, November 2020, AME Publishing Company

    MD, PhD Erion Xhepa

  143. Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

    Article • Journal of the American College of Cardiology, November 2020, Elsevier

    MD, PhD Erion Xhepa

  144. Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

    Article • JACC Cardiovascular Interventions, November 2020, Elsevier

    MD, PhD Erion Xhepa

  145. Aspartate aminotransferase and mortality in patients with ischemic heart disease

    Article • Nutrition Metabolism and Cardiovascular Diseases, November 2020, Elsevier

    MD, PhD Erion Xhepa

  146. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells

    Article • The International Journal of Cardiovascular Imaging, August 2020, Springer Science + Business Media

    MD, PhD Erion Xhepa

  147. 10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents

    Article • Journal of the American College of Cardiology, July 2020, Elsevier

    MD, PhD Erion Xhepa

  148. Early Outcome in Patients Requiring Conversion to General Anesthesia During Transfemoral Transcatheter Aortic Valve Implantation

    Article • The American Journal of Cardiology, July 2020, Elsevier

    MD, PhD Erion Xhepa

  149. Successful Repeat Transcatheter Mitral Valve Replacement After Late Prosthesis Failure

    Article • JACC Cardiovascular Interventions, June 2020, Elsevier

    MD, PhD Erion Xhepa

  150. Simultaneous ballooning and transcatheter valve implantation as a back-up maneuver in bicuspid aortic valve with horizontal aorta

    Article • Clinical Research in Cardiology, May 2020, Springer Science + Business Media

    MD, PhD Erion Xhepa

  151. Hypothermia in patients with acute myocardial infarction: a meta-analysis of randomized trials

    Article • Clinical Research in Cardiology, April 2020, Springer Science + Business Media

    MD, PhD Erion Xhepa

  152. 1000 mm2 plus aortic annulus: successful treatment of a giant bicuspid aortic valve with a Sapien 3 transcatheter heart valve

    Article • European Heart Journal, March 2020, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  153. Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest – A propensity score-matched analysis

    Article • PLOS One, January 2020, PLOS

    MD, PhD Erion Xhepa

  154. Hypocholesterolaemia and mortality in patients with coronary artery disease

    Article • European Journal of Clinical Investigation, January 2020, Wiley

    MD, PhD Erion Xhepa

  155. Relation of Hypocholesterolemia With Diabetes Mellitus in Patients With Coronary Artery Disease

    Article • The American Journal of Cardiology, January 2020, Elsevier

    MD, PhD Erion Xhepa

  156. Efficacy of drug‐coated balloon angioplasty in early versus late occurring drug‐eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials

    Article • Catheterization and Cardiovascular Interventions, December 2019, Wiley

    MD, PhD Erion Xhepa

  157. Paravalvular leakage due to ring dehiscence after mitral valve-in-ring therapy: mechanisms and percutaneous treatment

    Article • European Heart Journal, November 2019, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  158. Association of shock index with short-term and long-term prognosis after ST-segment elevation myocardial infarction

    Article • Coronary Artery Disease, October 2019, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  159. TCT-283 10-Year Clinical Outcomes From a Trial of 3 Limus-Eluting Stents With Different Polymer Coatings in Diabetic Patients With Coronary Artery Disease: Results From the ISAR-TEST 4 Randomized Trial

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    MD, PhD Erion Xhepa

  160. TCT-711 Prevalence and Clinical Impact of Bioprosthesis Thrombosis After Transcatheter Aortic Valve Implantation. A Collaborative Meta-Analysis

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    MD, PhD Erion Xhepa

  161. TCT-97 Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions Mid-Term Angiographic and Optical Coherence Tomography Findings from the ISAR-OCT-CTO Registry

    Article • Journal of the American College of Cardiology, October 2019, Elsevier

    MD, PhD Erion Xhepa

  162. Inverse association of alanine aminotransferase within normal range with prognosis in patients with coronary artery disease

    Article • Clinica Chimica Acta, September 2019, Elsevier

    MD, PhD Erion Xhepa

  163. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2019, New England Journal of Medicine (NEJM/MMS)

    MD, PhD Erion Xhepa

  164. Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions

    Article • JACC Cardiovascular Interventions, September 2019, Elsevier

    MD, PhD Erion Xhepa

  165. Simultaneous Transseptal Mitral Valve-in-Valve and Trans-Bypass Aortic Valve Treatment Using Balloon-Expandable Valves

    Article • JACC Cardiovascular Interventions, September 2019, Elsevier

    MD, PhD Erion Xhepa

  166. Procedural and clinical performance of dual‐ versus single‐catheter strategy for transradial coronary angiography: A meta‐analysis of randomized trials

    Article • Catheterization and Cardiovascular Interventions, August 2019, Wiley

    MD, PhD Erion Xhepa

  167. Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials

    Article • EuroIntervention, August 2019, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  168. Two birds with one stone: transcatheter valve-in-valve treatment of a failed surgical bioprosthesis with concomitant severe stenosis and paravalvular leak

    Article • Clinical Research in Cardiology, July 2019, Springer Science + Business Media

    MD, PhD Erion Xhepa

  169. Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest – a propensity score-matched analysis

    Article • June 2019, Cold Spring Harbor Laboratory Press

    MD, PhD Erion Xhepa

  170. Optical coherence tomography tissue coverage and characterization with grey-scale signal intensity analysis after bifurcation stenting with a new generation bioabsorbable polymer drug-eluting stent

    Article • Cardiovascular Revascularization Medicine, May 2019, Elsevier

    MD, PhD Erion Xhepa

  171. Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis

    Article • Clinical Research in Cardiology, February 2019, Springer Science + Business Media

    MD, PhD Erion Xhepa

  172. Relationship of left ventricular end-diastolic pressure with extent of myocardial ischemia, myocardial salvage and long-term outcome in patients with ST-segment elevation myocardial infarction

    Article • Catheterization and Cardiovascular Interventions, January 2019, Wiley

    MD, PhD Erion Xhepa

  173. U-shaped association of central pulse pressure with long-term prognosis after ST-segment elevation myocardial infarction

    Article • Heart and Vessels, January 2019, Springer Science + Business Media

    MD, PhD Erion Xhepa

  174. Relation of Ratio of Left Ventricular Ejection Fraction to Left Ventricular End-Diastolic Pressure to Long-Term Prognosis After ST-Segment Elevation Acute Myocardial Infarction

    Article • The American Journal of Cardiology, January 2019, Elsevier

    MD, PhD Erion Xhepa

  175. International LAMPOON: first European experience with laceration of the anterior mitral valve leaflet prior to transseptal transcatheter mitral valve implantation

    Article • EuroIntervention, September 2018, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  176. High-sensitivity cardiac troponin T and prognosis in patients with ST-segment elevation myocardial infarction

    Article • Journal of Cardiology, September 2018, Elsevier

    MD, PhD Erion Xhepa

  177. P2273Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  178. P4559Outcome after single-layer polytetrafluoroethylene-covered stent implantation for the treatment of coronary artery perforation

    Article • European Heart Journal, August 2018, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  179. Neoatherosclerosis in Patients With Coronary Stent Thrombosis

    Article • JACC Cardiovascular Interventions, July 2018, Elsevier

    MD, PhD Erion Xhepa

  180. Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

    Article • EuroIntervention, June 2018, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  181. Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study

    Article • International Journal of Cardiology, May 2018, Elsevier

    MD, PhD Erion Xhepa

  182. Reduction of thrombus burden

    Article • Coronary Artery Disease, May 2018, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  183. Sex differences in the outcome after percutaneous coronary intervention – A propensity matching analysis

    Article • Cardiovascular Revascularization Medicine, May 2018, Elsevier

    MD, PhD Erion Xhepa

  184. Neoatherosclerosis: from basic principles to intravascular imaging

    Article • Minerva Cardiology and Angiology, May 2018, Edizioni Minerva Medica

    MD, PhD Erion Xhepa

  185. Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials

    Article • European Heart Journal - Cardiovascular Imaging, January 2018, Oxford University Press (OUP)

    MD, PhD Erion Xhepa

  186. A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart disease

    Article • Nutrition Metabolism and Cardiovascular Diseases, January 2018, Elsevier

    MD, PhD Erion Xhepa

  187. 37 Optical coherence tomography tissue coverage and characterization by grey-scale signal intensity analysis post bifurcation stenting with new generation bioabsorbable polymer everolimus-eluting stents

    Article • October 2017, BMJ

    MD, PhD Erion Xhepa

  188. Consequences of Vascular Calcification

    Article • JACC Cardiovascular Imaging, October 2017, Elsevier

    MD, PhD Erion Xhepa

  189. Prognostic value of alkaline phosphatase in patients with acute coronary syndromes

    Article • Clinical Biochemistry, October 2017, Elsevier

    MD, PhD Erion Xhepa

  190. Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials

    Article • EuroIntervention, October 2017, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  191. TCT-419 Long-term clinical outcomes of patients presenting with in-stent restenosis after drug-eluting stent implantation for unprotected left main coronary artery. A pooled analysis of the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 randomized trials

    Article • Journal of the American College of Cardiology, October 2017, Elsevier

    MD, PhD Erion Xhepa

  192. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis

    Article • Circulation, September 2017, Wolters Kluwer Health

    MD, PhD Erion Xhepa

  193. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents

    Article • JACC Cardiovascular Interventions, July 2017, Elsevier

    MD, PhD Erion Xhepa

  194. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

    Article • Catheterization and Cardiovascular Interventions, May 2017, Wiley

    Professor Gjin Ndrepepa, MD, PhD Erion Xhepa

  195. Alkaline phosphatase and prognosis in patients with coronary artery disease

    Article • European Journal of Clinical Investigation, April 2017, Wiley

    Professor Gjin Ndrepepa, MD, PhD Erion Xhepa

  196. Gamma-glutamyl transferase and atrial fibrillation in patients with coronary artery disease

    Article • Clinica Chimica Acta, February 2017, Elsevier

    MD, PhD Erion Xhepa

  197. TCT-399 Impact of post-dilatation on angiographic and clinical outcomes of patients undergoing bioresorbable scaffold implantation in clinical practice

    Article • Journal of the American College of Cardiology, November 2016, Elsevier

    MD, PhD Erion Xhepa

  198. TCT-414 Two-year outcomes of patients with acute coronary syndrome versus stable coronary disease undergoing bioresorbable scaffold implantation

    Article • Journal of the American College of Cardiology, November 2016, Elsevier

    MD, PhD Erion Xhepa

  199. TCT-58 Long-term clinical outcomes of patients treated with everolimus-eluting bioresorbable scaffolds during daily practice – 2-year results from the ISAR-ABSORB Registry

    Article • Journal of the American College of Cardiology, November 2016, Elsevier

    MD, PhD Erion Xhepa

  200. Optical coherence tomography in drug‑eluting stent restenosis: a technique in need of a strategy

    Article • Minerva Cardiology and Angiology, November 2016, Edizioni Minerva Medica

    MD, PhD Erion Xhepa

  201. Biodegradable-polymer drug-eluting stents: back to the future?

    Article • Heart, September 2016, BMJ

    MD, PhD Erion Xhepa

  202. Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis

    Article • Catheterization and Cardiovascular Interventions, August 2016, Wiley

    MD, PhD Erion Xhepa

  203. Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials

    Article • Catheterization and Cardiovascular Interventions, August 2016, Wiley

    MD, PhD Erion Xhepa

  204. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials

    Article • Clinical Research in Cardiology, December 2015, Springer Science + Business Media

    MD, PhD Erion Xhepa

  205. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium

    Article • European Heart Journal, August 2015, European Society of Cardiology

    MD, PhD Erion Xhepa

  206. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment

    Article • European Heart Journal, May 2015, European Society of Cardiology

    Dr Michael Joner, MD, PhD Erion Xhepa

  207. TCT-373 Temporal course of neointimal maturity after implantation of biodegradable polymer sirolimus-eluting stents as assessed by optical coherence tomography gray-scale signal intensity at 3, 6 and 9 months

    Article • Journal of the American College of Cardiology, September 2014, Elsevier

    MD, PhD Erion Xhepa

  208. Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site – CLOSURE device versus manual...

    Article • EuroIntervention, June 2014, Europa Digital & Publishing

    MD, PhD Erion Xhepa

  209. Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort

    Article • Indian Heart Journal, May 2014, Elsevier

    MD, PhD Erion Xhepa

  210. TCT-591 Stent coverage and neointimal maturity in a randomized trial of limus-eluting stents with biodegradable polymer versus permanent polymer coatings assessed by optical coherence tomography

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    MD, PhD Erion Xhepa